Our Pricing

Buy Mounjaro NHS: Weight Loss Injections UK

Looking to buy Mounjaro NHS UK online with the same clinical rigour you'd expect from your GP? At Cured Pharmacy, our UK-registered prescribers provide comprehensive weight loss assessments, genuine tirzepatide injections from £135.00, and discreet next-day delivery across the UK. Every prescription follows MHRA guidelines and requires a clinical consultation with our pharmacist-led team.

How Mounjaro (Tirzepatide) Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for chronic weight management in the UK [1]. Unlike single-pathway treatments such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors simultaneously, producing enhanced effects on appetite regulation, insulin secretion, and gastric emptying.

In the landmark SURMOUNT-1 trial, participants receiving the 15mg maintenance dose of tirzepatide achieved an average body weight reduction of 22.5% over 72 weeks, compared to 2.4% with placebo [1]. This dual-receptor mechanism also improved glycaemic control and cardiovascular risk markers, making tirzepatide particularly effective for patients with obesity-related comorbidities.

The medication works by mimicking natural incretin hormones that regulate blood sugar and satiety signals. Patients typically report reduced hunger, earlier feelings of fullness, and fewer cravings within the first few weeks of treatment [2]. These effects are dose-dependent and strengthen as you progress through the titration schedule under your prescriber's guidance.

Mounjaro vs Wegovy: Comparing Weight Loss Injections UK

Both Mounjaro and Wegovy are MHRA-licensed injectable treatments for chronic weight management, but they differ in their pharmacological mechanisms and clinical outcomes. Wegovy contains semaglutide, a GLP-1 receptor agonist that has demonstrated average weight loss of 14.9% over 68 weeks in the STEP-1 trial [3]. Mounjaro's dual GIP/GLP-1 action has shown superior weight reduction in head-to-head comparisons.

The SURPASS-2 trial directly compared tirzepatide with semaglutide 1mg in patients with type 2 diabetes, finding that the highest tirzepatide dose produced significantly greater weight loss than the semaglutide comparator [4]. While both medications require once-weekly subcutaneous injection and follow similar titration protocols, individual response varies based on metabolic factors, tolerance, and adherence.

Your UK prescriber will assess your medical history, current medications, weight loss goals, and any contraindications before recommending either treatment. Both options are available at Cured Pharmacy following clinical approval, with transparent pricing displayed before your consultation begins.

Choosing Between Mounjaro and Wegovy

Patients with previous GLP-1 experience may benefit from switching to tirzepatide if weight loss has plateaued, whilst those new to injectable treatments often start with the option their prescriber deems most suitable based on individual risk factors. Neither medication is inherently superior—clinical trials show both produce significant weight reduction when combined with lifestyle modifications [1][3]. Our pharmacist-led team, overseen by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), ensures you receive evidence-based guidance tailored to your clinical profile.

Mounjaro Dosing Schedule and Administration

Mounjaro is supplied in pre-filled KwikPen injectors containing single doses ranging from 2.5mg to 15mg. The standard titration schedule begins with 2.5mg once weekly for four weeks, increasing every four weeks to 5mg, 7.5mg, 10mg, 12.5mg, and finally 15mg as tolerated [5]. This gradual escalation minimises gastrointestinal side effects whilst allowing your body to adapt to the medication's metabolic effects.

Each injection is administered subcutaneously into the abdomen, thigh, or upper arm on the same day each week. The KwikPen design simplifies self-administration—patients report high confidence after the first supervised injection. Unused pens must be refrigerated between 2°C and 8°C, though they may be kept at room temperature (up to 30°C) for up to 21 days if needed.

Your prescriber determines your maintenance dose based on weight loss response and tolerability. Some patients achieve their goals at 10mg weekly, whilst others require the maximum 15mg dose for optimal results [1]. Dose adjustments are made during follow-up consultations, which our clinical team schedules at appropriate intervals throughout your treatment journey.

What to Expect in Your First Month

During the initial 2.5mg phase, most patients experience mild appetite suppression and occasional nausea, which typically resolves within one to two weeks. Weight loss during this starter phase averages 2-4% of body weight, with more significant reductions occurring as doses increase [2]. Our clinical team provides detailed injection technique guidance, side effect management strategies, and dietary recommendations to optimise your first-month experience and build sustainable habits for long-term success.

Mounjaro Price UK: Transparent Pharmacy Costs

At Cured Pharmacy, Mounjaro is available from £135.00 per four-week supply, with pricing varying by prescribed dose strength. We display exact costs upfront before your consultation begins—no hidden fees, no surprise charges at checkout. This transparent approach reflects our commitment to accessible weight management care across the UK.

The price includes your medication, clinical assessment by a UK-registered prescriber, and discreet delivery to your address. Unlike some providers who advertise low starter prices but increase costs at higher maintenance doses, our pricing structure remains competitive throughout your treatment journey. We also guarantee you're receiving genuine UK-licensed Mounjaro pens sourced directly through regulated pharmaceutical supply chains.

Patients often ask whether Mounjaro is available on the NHS. Currently, tirzepatide is licensed for type 2 diabetes management on NHS prescription, but NICE guidance for obesity treatment is still under evaluation. Private prescription through registered online pharmacies like Cured remains the primary access route for weight management indications. Our clinical team can discuss all available options during your free consultation.

Common Side Effects and Safety Considerations

The most frequently reported side effects of Mounjaro are gastrointestinal: nausea (31-44% of patients), diarrhoea (19-23%), vomiting (10-18%), and constipation (11-17%) [5]. These effects are typically mild to moderate, occur most commonly during dose escalation, and diminish with continued use. Eating smaller meals, avoiding high-fat foods, and staying well-hydrated can significantly reduce GI discomfort.

Serious but rare adverse events include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking concurrent diabetes medications). Mounjaro carries a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though no causal link has been established in humans [5]. It is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Before prescribing Mounjaro, your UK clinician will review your complete medical history, including any history of pancreatitis, diabetic retinopathy, renal impairment, or eating disorders. Pregnant or breastfeeding women should not use tirzepatide, and patients planning pregnancy should discontinue treatment at least two months before conception. Our pharmacist-led team provides ongoing safety monitoring throughout your treatment course.

Managing Side Effects Effectively

If you experience persistent nausea, our clinical team recommends ginger supplements, small frequent meals, and avoiding lying down immediately after eating. Most patients find side effects peak 1-3 days post-injection and resolve by day five. Severe or worsening symptoms warrant immediate contact with your prescriber—our pharmacy team is available on (+44) 116 4646009 during business hours for clinical guidance and support.

How to Buy Mounjaro Online UK from Cured Pharmacy

Purchasing Mounjaro through Cured Pharmacy begins with a free online consultation that takes under three minutes to complete. You'll answer questions about your weight history, current health conditions, medications, and weight loss goals. This information is reviewed by a UK-registered prescriber (doctor or independent prescriber) who determines whether Mounjaro is clinically appropriate for you.

If approved, your prescription is sent electronically to our GPhC-registered pharmacy (registration number 9012511), where our team dispenses genuine UK-licensed Mounjaro pens. We offer next-day delivery in discreet, unmarked packaging across the UK. If the prescriber determines Mounjaro isn't suitable, they may recommend alternative treatments such as Wegovy or Saxenda, or advise consultation with your NHS GP for further evaluation.

All prescription weight loss medications at Cured Pharmacy require clinical approval—we never dispense tirzepatide without a valid UK prescription. This safeguards patient safety and ensures compliance with MHRA regulations and GPhC standards. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), personally oversees clinical governance and medication quality assurance across all dispensing operations.

Ongoing Clinical Support and Follow-Up

Weight loss treatment is most effective when combined with dietary modifications and increased physical activity. Our clinical team provides evidence-based lifestyle guidance alongside your Mounjaro prescription, and schedules follow-up assessments to monitor progress, adjust dosing, and address any concerns. This comprehensive approach mirrors the multidisciplinary care model recommended by NICE for obesity management, delivered conveniently through our online platform with the same clinical rigour you'd expect from face-to-face NHS services.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
3. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
4. Ludvik, B., Giorgino, F., Jódar, E., et al. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583–598. https://doi.org/10.1016/S0140-6736(21)01443-4
5. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen – Summary of Product Characteristics (SmPC). https://www.medicines.org.uk/emc/product/14881

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to prescribed treatment, lifestyle modifications, and individual metabolic factors.